TY  - GEN 
AU  - Cabello-Ubeda, A.
AU  - de Quirós, J.C.L.B.
AU  - Carbonero, L.M.
AU  - Sanz, J.
AU  - Vergas, J.
AU  - Mena de Cea, Alvaro
AU  - Torralba, M.
AU  - Segurado, M.H.
AU  - Pinto, A.
AU  - Tejerina, F.
AU  - Palmier, E.
AU  - Gutiérrez, Á.
AU  - Vázquez, P.
AU  - Pulido, F.
AU  - Górgolas, M.
PY  - 2022
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.11940/20751
AB  - Background The main international guidelines indicate DTG/3TC therapy as one of the preferred regimens for people living with HIV (PLWH), due to its observed efficacy in randomized clinical trials. However, information in real-life cohorts is...
LA  - eng
TI  - 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort
DO  - 10.1371/journal.pone.0277606
KW  - AS Coruña
KW  - CHUAC
KW  - INIBIC
VL  - 17
ER  -